id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2301181,d79ecd4e-e44b-4d9e-ad14-a8e692be2322,Q2,"MARSHALL & POPP, LLC",401105121,"SANOFI U.S. SERVICES, INC.",2019,second_quarter,PHA,"Prescription drug value issues.

Biosimilars.

Importation of prescription drugs.

340B issues.

FDA regulatory issues, including the International Pricing Index and Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Office of Management & Budget (OMB),White House Office",40000,,0,0,2019-07-10T16:56:55.787000-04:00